Peinado MA - Search Results

1

Prognostic value of genomic damage in non-small-cell lung cancer.

de Juan C, Iniesta P, Vega FJ, Peinado MA, Fernandez C, Caldés T, Massa MJ, López JA, Sánchez A, Torres AJ, Balibrea JL, Benito M. de Juan C, et al. Among authors: peinado ma. Br J Cancer. 1998 Jun;77(11):1971-7. doi: 10.1038/bjc.1998.327. Br J Cancer. 1998. PMID: 9667677 Free PMC article.

2

Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer.

Masramon L, Arribas R, Tórtola S, Perucho M, Peinado MA. Masramon L, et al. Among authors: peinado ma. Br J Cancer. 1998 Jun;77(12):2349-56. doi: 10.1038/bjc.1998.390. Br J Cancer. 1998. PMID: 9649157 Free PMC article.

3

Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications.

Arribas R, Capellà G, Tórtola S, Masramon L, Grizzle WE, Perucho M, Peinado MA. Arribas R, et al. Among authors: peinado ma. J Clin Oncol. 1997 Oct;15(10):3230-40. doi: 10.1200/JCO.1997.15.10.3230. J Clin Oncol. 1997. PMID: 9336360

4

Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer.

Risques RA, Moreno V, Ribas M, Marcuello E, Capellà G, Peinado MA. Risques RA, et al. Among authors: peinado ma. Cancer Res. 2003 Nov 1;63(21):7206-14. Cancer Res. 2003. PMID: 14612515

5

DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.

Mancikova V, Buj R, Castelblanco E, Inglada-Pérez L, Diez A, de Cubas AA, Curras-Freixes M, Maravall FX, Mauricio D, Matias-Guiu X, Puig-Domingo M, Capel I, Bella MR, Lerma E, Castella E, Reverter JL, Peinado MÁ, Jorda M, Robledo M. Mancikova V, et al. Among authors: peinado ma. Int J Cancer. 2014 Aug 1;135(3):598-610. doi: 10.1002/ijc.28703. Epub 2014 Jan 13. Int J Cancer. 2014. PMID: 24382797

6

Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas.

Muñoz J, Vendrell E, Aiza G, Nistal M, Pestaña A, Peinado MA, Castresana JS. Muñoz J, et al. Among authors: peinado ma. Neuropathology. 2006 Jun;26(3):165-9. doi: 10.1111/j.1440-1789.2006.00675.x. Neuropathology. 2006. PMID: 16771170

7

Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease.

Mayor R, Casadomé L, Azuara D, Moreno V, Clark SJ, Capellà G, Peinado MA. Mayor R, et al. Among authors: peinado ma. Br J Cancer. 2009 May 19;100(10):1534-9. doi: 10.1038/sj.bjc.6605045. Epub 2009 Apr 21. Br J Cancer. 2009. PMID: 19384295 Free PMC article.

8

Genomic determinants of prognosis in colorectal cancer.

Vendrell E, Morales C, Risques RA, Capellà G, Peinado MA. Vendrell E, et al. Among authors: peinado ma. Cancer Lett. 2005 Apr 18;221(1):1-9. doi: 10.1016/j.canlet.2004.08.023. Cancer Lett. 2005. PMID: 15797621 Review.

9

Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer.

Berrozpe G, Schaeffer J, Peinado MA, Real FX, Perucho M. Berrozpe G, et al. Among authors: peinado ma. Int J Cancer. 1994 Jul 15;58(2):185-91. doi: 10.1002/ijc.2910580207. Int J Cancer. 1994. PMID: 8026879

10

p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.

Tortola S, Marcuello E, González I, Reyes G, Arribas R, Aiza G, Sancho FJ, Peinado MA, Capella G. Tortola S, et al. Among authors: peinado ma. J Clin Oncol. 1999 May;17(5):1375-81. doi: 10.1200/JCO.1999.17.5.1375. J Clin Oncol. 1999. PMID: 10334521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page